Reading the molecules of immunity.
Onuris is developing a nanopore-based platform to directly sequence antibodies for discovery, engineering, and biomanufacturing.
Onuris is developing a nanopore-based platform to directly sequence antibodies for discovery, engineering, and biomanufacturing.